ITTO960477A0 - Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil. - Google Patents

Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.

Info

Publication number
ITTO960477A0
ITTO960477A0 ITTO960477A ITTO960477A ITTO960477A0 IT TO960477 A0 ITTO960477 A0 IT TO960477A0 IT TO960477 A ITTO960477 A IT TO960477A IT TO960477 A ITTO960477 A IT TO960477A IT TO960477 A0 ITTO960477 A0 IT TO960477A0
Authority
IT
Italy
Prior art keywords
fentanil
electrotransport
sufentanil
procedure
transdermal administration
Prior art date
Application number
ITTO960477A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23848034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITTO960477(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of ITTO960477A0 publication Critical patent/ITTO960477A0/it
Publication of ITTO960477A1 publication Critical patent/ITTO960477A1/it
Application granted granted Critical
Publication of IT1285387B1 publication Critical patent/IT1285387B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
IT96TO000477A 1995-06-05 1996-06-03 Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil. IT1285387B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/465,492 US6881208B1 (en) 1995-06-05 1995-06-05 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil

Publications (3)

Publication Number Publication Date
ITTO960477A0 true ITTO960477A0 (it) 1996-06-03
ITTO960477A1 ITTO960477A1 (it) 1997-12-03
IT1285387B1 IT1285387B1 (it) 1998-06-03

Family

ID=23848034

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96TO000477A IT1285387B1 (it) 1995-06-05 1996-06-03 Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.

Country Status (20)

Country Link
US (3) US6881208B1 (it)
JP (3) JPH11506684A (it)
KR (1) KR100431364B1 (it)
CN (1) CN1118308C (it)
AT (1) AT409088B (it)
AU (1) AU695465B2 (it)
BE (1) BE1009505A3 (it)
BR (1) BR9609137B1 (it)
CA (2) CA2219736C (it)
CH (1) CH690751A5 (it)
DE (1) DE19681420B4 (it)
FR (1) FR2736837B1 (it)
GB (1) GB2317115B (it)
GR (1) GR1002982B (it)
IE (1) IE960374A1 (it)
IT (1) IT1285387B1 (it)
NL (1) NL1003274C2 (it)
SE (1) SE521220C2 (it)
WO (1) WO1996039224A1 (it)
ZA (1) ZA964658B (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
WO1999038565A1 (en) 1998-01-28 1999-08-05 Alza Corporation Electrotransport electrode assembly having lower initial resistance
US6858018B1 (en) 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
ES2297941T3 (es) 1998-11-02 2008-05-01 Alza Corporation Dispositivo de electrotransporte que comprende un agente antimicrobiano compatible.
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6496727B1 (en) * 2000-05-31 2002-12-17 Becton, Dickinson And Company Medicament-loaded transdermal reservoir and method for its formation
DE60133203T3 (de) 2000-07-31 2012-02-23 Nycomed Danmark Aps Fentanyl Zusammensetzung für nasale Anwendung
EP1317306B1 (en) * 2000-09-11 2005-04-20 Alza Corporation Transdermal electrotransport device and method for manufacturing same
CA2443326A1 (en) 2001-04-04 2002-10-17 Alza Corporation Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2004002571A1 (en) * 2002-06-28 2004-01-08 Alza Corporation A reservoir for use in an electrotransport drug delivery device
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
KR100730582B1 (ko) * 2006-11-20 2007-06-20 아람휴비스(주) 이온토포레시스 장치
EP2101864A2 (en) * 2006-12-20 2009-09-23 ALZA Corporation Anode for electrotransport of cationic drug
EP2043733A1 (en) * 2007-06-26 2009-04-08 Alza Corporation Methods and devices for transdermal electrotransport delivery of lofentanil and carfentanil
US20090105634A1 (en) * 2007-10-17 2009-04-23 Alza Corporation Anodic Reservoir for Electrotransport of Cationic Drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride
WO2009123970A2 (en) * 2008-04-01 2009-10-08 Alza Corporation Electrotransport fentanyl delivery device with consistent delivery
CN102159205A (zh) * 2008-06-25 2011-08-17 Fe3医学有限公司 用于经皮递送治疗有效量的铁的贴片和方法
US20100004583A1 (en) * 2008-07-01 2010-01-07 Alza Corporation Hydrophobic Circuit Board Coating of Electrotransport Drug Delivery Devices
CA2735785C (en) * 2008-09-02 2015-01-27 Travanti Pharma Inc. Sacrificial electrode design and delivery species suitable for prolonged iontophoresis application periods
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
BRPI0923808A2 (pt) 2008-12-30 2015-07-14 Nupathe Inc Controle eletrônico de sistema de distribuição de fármaco
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
WO2010107761A1 (en) 2009-03-18 2010-09-23 Acelrx Pharmaceuticals, Inc. Improved storage and dispensing devices for administration of oral transmucosal dosage forms
US8821945B2 (en) * 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
JP2012524604A (ja) * 2009-04-25 2012-10-18 インキューブ ラブズ， エルエルシー キレート剤の経皮的イオン導入送達のための方法
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
KR101955175B1 (ko) 2010-04-13 2019-03-06 나지브 바불 1-메틸-2'-6'-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
EP2643048A1 (en) 2010-11-23 2013-10-02 Nupathe Inc. User-activated self-contained co-packaged iontophoretic drug delivery system
AU2012230701B2 (en) * 2011-03-24 2016-09-29 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
ES2716570T3 (es) 2012-04-17 2019-06-13 Purdue Pharma Lp Sistemas y procedimientos para tratar o prevenir una respuesta farmacodinámica adversa inducida por opioides
BR112017013311B1 (pt) 2014-12-23 2022-05-31 Acelrx Pharmaceuticals, Inc Aparelho para a dispensação de formas de dosagem via oral e transmucosal
KR20250166945A (ko) 2023-03-28 2025-11-28 기꼬만 가부시키가이샤 경피 통전 패치

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5135479A (en) 1983-08-18 1992-08-04 Drug Delivery Systems, Inc. Programmable control and mounting system for transdermal drug applicator
US5224928A (en) 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US5135477A (en) 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4752285B1 (en) 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) * 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US5006108A (en) 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5320597A (en) 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5232448A (en) 1989-12-05 1993-08-03 Prime Medical Products Patient-controlled analgesia device
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
IT1244030B (it) 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
ES2082973T3 (es) * 1990-03-30 1996-04-01 Alza Corp Dispositivo para administracion iontoforetica de farmacos.
US5125894A (en) * 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
US5224927A (en) 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US5254081A (en) 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5203768A (en) 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
US5298017A (en) 1992-12-29 1994-03-29 Alza Corporation Layered electrotransport drug delivery system
US7027859B1 (en) * 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
US6216033B1 (en) * 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil

Also Published As

Publication number Publication date
DE19681420B4 (de) 2009-05-28
CH690751A5 (de) 2001-01-15
KR19990022342A (ko) 1999-03-25
ATA903696A (de) 2001-10-15
KR100431364B1 (ko) 2004-07-16
US20050171464A1 (en) 2005-08-04
JP4616309B2 (ja) 2011-01-19
SE521220C2 (sv) 2003-10-14
CA2219736C (en) 2008-02-12
CN1187142A (zh) 1998-07-08
ITTO960477A1 (it) 1997-12-03
GR1002982B (el) 1998-10-01
FR2736837A1 (fr) 1997-01-24
AU6257896A (en) 1996-12-24
GR960100178A (el) 1997-02-28
ZA964658B (en) 1997-02-03
BR9609137B1 (pt) 2010-06-29
CA2613061C (en) 2010-02-09
DE19681420T1 (de) 1998-05-20
NL1003274C2 (nl) 1998-11-03
AU695465B2 (en) 1998-08-13
CA2219736A1 (en) 1996-12-12
JP4070779B2 (ja) 2008-04-02
SE9704103L (sv) 1997-11-10
NL1003274A1 (nl) 1996-12-06
GB2317115A (en) 1998-03-18
IE960374A1 (en) 1996-12-11
JP2005261970A (ja) 2005-09-29
CA2613061A1 (en) 1996-12-12
JP2007237002A (ja) 2007-09-20
GB9725542D0 (en) 1998-02-04
IT1285387B1 (it) 1998-06-03
CN1118308C (zh) 2003-08-20
US20050131337A1 (en) 2005-06-16
JPH11506684A (ja) 1999-06-15
FR2736837B1 (fr) 1998-07-24
BE1009505A3 (fr) 1997-04-01
WO1996039224A1 (en) 1996-12-12
SE9704103D0 (sv) 1997-11-10
US6881208B1 (en) 2005-04-19
AT409088B (de) 2002-05-27
BR9609137A (pt) 1999-02-17
GB2317115B (en) 1999-08-04

Similar Documents

Publication Publication Date Title
ITTO960469A0 (it) Dispositivo per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ITTO960488A0 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
FI955259L (fi) Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
NL1003300A1 (nl) Implanteerbare therapeutische inrichting.
KR950703383A (ko) 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
FI954990L (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
DE69430186D1 (de) Aktive implantierbare Vorrichtung
DE69218932D1 (de) Transdermale therapeutische Formulierung
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
DE69614680D1 (de) Implantierbare osteosynthesevorrichtung
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
NO950725D0 (no) Trykket transdermal medikamentavleveringsinnretning
NO973471D0 (no) Transdermal formulering
ITBO910351A0 (it) Elettrodo ad ancoraggio attivo per elettrocateteri
FI962220L (fi) Transdermaalinen terapeuttinen järjestelmä
FI962550A7 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoitukses sa
ITRM910963A0 (it) Composizione farmaceutica effervescente anticefalalgica e metodo per prepararla ed applicarla.
ITRM940140A0 (it) Procedimento e dispositivo per la produzione di potassa.
FI932786L (fi) Vaikuttavaa ainetta luovuttava laite
ITMI921573A0 (it) Dispositivo di somministrazione di farmaci particolarmente per aerosolterapia e simili
ITRM930279A0 (it) Dispositivo di supporto per attrezzature ginniche e/o terapeutiche.
ITPD950009A0 (it) Dispositivo per terapie di elettrostimolazione

Legal Events

Date Code Title Description
0001 Granted